HCV upregulates Bim through the ROS/JNK signalling pathway, leading to Bax-mediated apoptosis

Journal of General Virology

Volumn 96, Issue 9, 2015, Pages 2670-2683

  Deng, Lin ^a   Chen, Ming ^a   Tanaka, Motofumi ^a   Ku, Yonson ^a   Itoh, Tomoo ^a   Shoji, Ikuo ^a   Hotta, Hak ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BIM PROTEIN; MESSENGER RNA; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; APOPTOSIS REGULATORY PROTEIN; BAX PROTEIN, HUMAN; BCL-2-LIKE PROTEIN 11; CASPASE 3; CYTOCHROME C; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; ONCOPROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HEPATITIS C VIRUS; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; ENZYMOLOGY; GENETICS; HEPACIVIRUS; HEPATITIS C; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE; VIROLOGY;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE, TUMOR; CYTOCHROMES C; HEPACIVIRUS; HEPATITIS C; HUMANS; MAP KINASE KINASE 4; MEMBRANE PROTEINS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84973411894     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000221     Document Type: Article

References (57)

1. Bantel, H. & Schulze-Osthoff, K. (2003). Apoptosis in hepatitis C virus infection. Cell Death Differ 10 (Suppl. 1), S48–S58.
2. Blight, K. J., McKeating, J. A. & Rice, C. M. (2002). Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76, 13001–13014.
3. Buccellato, L. J., Tso, M., Akinci, O. I., Chandel, N. S. & Budinger, G. R. (2004). Reactive oxygen species are required for hyperoxiainduced Bax activation and cell death in alveolar epithelial cells. J Biol Chem 279, 6753–6760.
4. Bumpus, N. N. (2011). Efavirenz and 8-hydroxyefavirenz induce cell death via a JNK- and BimEL-dependent mechanism in primary human hepatocytes. Toxicol Appl Pharmacol 257, 227–234.
5. Bungyoku, Y., Shoji, I., Makine, T., Adachi, T., Hayashida, K., Nagano-Fujii, M., Ide, Y. H., Deng, L. & Hotta, H. (2009). Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells. J Gen Virol 90, 1681–1691.
6. Byun, J. Y., Kim, M. J., Eum, D. Y., Yoon, C. H., Seo, W. D., Park, K. H., Hyun, J. W., Lee, Y. S., Lee, J. S. & other authors (2009). Reactive oxygen species-dependent activation of Bax and poly(ADP-ribose) polymerase-1 is required for mitochondrial cell death induced by triterpenoid pristimerin in human cervical cancer cells. Mol Pharmacol 76, 734–744.
7. Calabrese, F., Pontisso, P., Pettenazzo, E., Benvegnù, L., Vario, A., Chemello, L., Alberti, A. & Valente, M. (2000). Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology 31, 1153–1159.
8. Chiou, H. L., Hsieh, Y. S., Hsieh, M. R. & Chen, T. Y. (2006). HCV E2 may induce apoptosis of Huh-7 cells via a mitochondrial-related caspase pathway. Biochem Biophys Res Commun 345, 453–458.
9. Czabotar, P. E., Colman, P. M. & Huang, D. C. (2009). Bax activation by Bim? Cell Death Differ 16, 1187–1191.
10. D’Alessio, M., De Nicola, M., Coppola, S., Gualandi, G., Pugliese, L., Cerella, C., Cristofanon, S., Civitareale, P., Ciriolo, M. R. & other authors (2005). Oxidative Bax dimerization promotes its translocation to mitochondria independently of apoptosis. FASEB J 19, 1504–1506.
11. Deng, L., Nagano-Fujii, M., Tanaka, M., Nomura-Takigawa, Y., Ikeda, M., Kato, N., Sada, K. & Hotta, H. (2006). NS3 protein of hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner. J Gen Virol 87, 1703–1713.
12. Deng, L., Adachi, T., Kitayama, K., Bungyoku, Y., Kitazawa, S., Ishido, S., Shoji, I. & Hotta, H. (2008). Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway. J Virol 82, 10375–10385.
13. Deng, L., Shoji, I., Ogawa, W., Kaneda, S., Soga, T., Jiang, D. P., Ide, Y. H. & Hotta, H. (2011). Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J Virol 85, 8556–8568.
14. Essafi, A., Fernańdez de Mattos, S., Hassen, Y. A., Soeiro, I., Mufti, G. J., Thomas, N. S., Medema, R. H. & Lam, E. W. (2005). Direct transcriptional regulation of Bim by FoxO3a mediates STI571- induced apoptosis in Bcr-Abl-expressing cells. Oncogene 24, 2317–2329.
15. Fabregat, I., Roncero, C. & Fernández, M. (2007). Survival and apoptosis: a dysregulated balance in liver cancer. Liver Int 27, 155–162.
16. Gao, M., Nettles, R. E., Belema, M., Snyder, L. B., Nguyen, V. N., Fridell, R. A., Serrano-Wu, M. H., Langley, D. R., Sun, J. H. & other authors (2010). Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 465, 96–100.
17. Gavathiotis, E., Suzuki, M., Davis, M. L., Pitter, K., Bird, G. H., Katz, S. G., Tu, H. C., Kim, H., Cheng, E. H. & other authors (2008). BAX activation is initiated at a novel interaction site. Nature 455, 1076–1081.
18. Gilley, J., Coffer, P. J. & Ham, J. (2003). FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 162, 613–622.
19. Guicciardi, M. E. & Gores, G. J. (2005). Apoptosis: a mechanism of acute and chronic liver injury. Gut 54, 1024–1033.
20. Heidari, N., Miller, A. V., Hicks, M. A., Marking, C. B. & Harada, H. (2012). Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells. Cell Death Dis 3, e349.
21. Hübner, A., Barrett, T., Flavell, R. A. & Davis, R. J. (2008). Multisite phosphorylation regulates Bim stability and apoptotic activity. Mol Cell 30, 415–425.
22. Inubushi, S., Nagano-Fujii, M., Kitayama, K., Tanaka, M., An, C., Yokozaki, H., Yamamura, H., Nuriya, H., Kohara, M. & other authors (2008). Hepatitis C virus NS5A protein interacts with and negatively regulates the non-receptor protein tyrosine kinase Syk. J Gen Virol 89, 1231–1242.
23. Joyce, M. A., Walters, K. A., Lamb, S. E., Yeh, M. M., Zhu, L. F., Kneteman, N., Doyle, J. S., Katze, M. G. & Tyrrell, D. L. (2009). HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice. PLoS Pathog 5, e1000291.
24. Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H. & Karin, M. (2005). Reactive oxygen species promote TNFa-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649–661.
25. Kasai, D., Adachi, T., Deng, L., Nagano-Fujii, M., Sada, K., Ikeda, M., Kato, N., Ide, Y. H., Shoji, I. & Hotta, H. (2009). HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters. J Hepatol 50, 883–894.
26. Kim, B. J., Ryu, S. W. & Song, B. J. (2006). JNK- and p38 kinasemediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem 281, 21256–21265.
27. Lalier, L., Cartron, P. F., Juin, P., Nedelkina, S., Manon, S., Bechinger, B. & Vallette, F. M. (2007). Bax activation and mitochondrial insertion during apoptosis. Apoptosis 12, 887–896.
28. Lee, S. K., Park, S. O., Joe, C. O. & Kim, Y. S. (2007). Interaction of HCV core protein with 14-3-3e protein releases Bax to activate apoptosis. Biochem Biophys Res Commun 352, 756–762.
29. Lei, K. & Davis, R. J. (2003). JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A 100, 2432–2437.
30. Ley, R., Ewings, K. E., Hadfield, K. & Cook, S. J. (2005). Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death Differ 12, 1008–1014.
31. Lin, W., Tsai, W. L., Shao, R. X., Wu, G., Peng, L. F., Barlow, L. L., Chung, W. J., Zhang, L., Zhao, H. & other authors (2010). Hepatitis C virus regulates transforming growth factor b1 production through the generation of reactive oxygen species in a nuclear factor kB-dependent manner. Gastroenterology 138, 2509–2518.
32. Lindenbach, B. D., Evans, M. J., Syder, A. J., Wölk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R. & other authors (2005). Complete replication of hepatitis C virus in cell culture. Science 309, 623–626.
33. Luciano, F., Jacquel, A., Colosetti, P., Herrant, M., Cagnol, S., Pages, G. & Auberger, P. (2003). Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene 22, 6785–6793.
34. Mateu, G., Donis, R. O., Wakita, T., Bukh, J. & Grakoui, A. (2008). Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death. Virology 376, 397–407.
35. Matsui, H., Asou, H. & Inaba, T. (2007). Cytokines direct the regulation of Bim mRNA stability by heat-shock cognate protein 70.Mol Cell 25, 99–112.
36. Matsui, C., Sianipar, I. R., Minami, N., Deng, L., Hotta, H. & Shoji, I. (2015). A single-amino-acid mutation in hepatitis C virus NS5A disrupts physical and functional interaction with the transcription factor HNF-1a. J Gen Virol. 2015 May 8. pii: vir.0.000179. doi: doi:10.1099/vir.0.000179. [Epub ahead of print].
37. Mengshol, J. A., Golden-Mason, L. & Rosen, H. R. (2007). Mechanisms of disease: HCV-induced liver injury. Nat Clin Pract Gastroenterol Hepatol 4, 622–634.
38. Mérino, D., Giam, M., Hughes, P. D., Siggs, O. M., Heger, K., O’Reilly, L. A., Adams, J. M., Strasser, A., Lee, E. F. & other authors (2009). The role of BH3-only protein Bim extends beyond inhibiting Bcl-2- like prosurvival proteins. J Cell Biol 186, 355–362.
39. Nie, C., Tian, C., Zhao, L., Petit, P. X., Mehrpour, M. & Chen, Q. (2008). Cysteine 62 of Bax is critical for its conformational activation and its proapoptotic activity in response to H2O2-induced apoptosis. J Biol Chem 283, 15359–15369.
40. Nomura-Takigawa, Y., Nagano-Fujii, M., Deng, L., Kitazawa, S., Ishido, S., Sada, K. & Hotta, H. (2006). Non-structural protein 4A of hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis. J Gen Virol 87, 1935–1945.
41. O’Connor, L., Strasser, A., O’Reilly, L. A., Hausmann, G., Adams, J. M., Cory, S. & Huang, D. C. (1998). Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 17, 384–395.
42. Okuno, S., Saito, A., Hayashi, T. & Chan, P. H. (2004). The c-Jun N-terminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient focal cerebral ischemia. J Neurosci 24, 7879–7887.
43. Oliver, F. J., Menissier-de Murcia, J. & de Murcia, G. (1999). Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease. Am J Hum Genet 64, 1282–1288.
44. Putcha, G. V., Le, S., Frank, S., Besirli, C. G., Clark, K., Chu, B., Alix, S., Youle, R. J., LaMarche, A. & other authors (2003). JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. Neuron 38, 899–914.
45. Seki, E., Brenner, D. A. & Karin, M. (2012). A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 143, 307–320.
46. Shepard, C. W., Finelli, L. & Alter, M. J. (2005). Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5, 558–567.
47. Singh, R., Wang, Y., Schattenberg, J. M., Xiang, Y. & Czaja, M. J. (2009). Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK/c-Jun overactivation. Am J Physiol Gastrointest Liver Physiol 297, G907–G917.
48. Strasser, A., Cory, S. & Adams, J. M. (2011). Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J 30, 3667–3683.
49. Tait, S. W. & Green, D. R. (2010). Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11, 621–632.
50. Tsuruta, F., Sunayama, J., Mori, Y., Hattori, S., Shimizu, S., Tsujimoto, Y., Yoshioka, K., Masuyama, N. & Gotoh, Y. (2004). JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J 23, 1889–1899.
51. Upton, J. P., Valentijn, A. J., Zhang, L. & Gilmore, A. P. (2007). The N-terminal conformation of Bax regulates cell commitment to apoptosis. Cell Death Differ 14, 932–942.
52. Vela, L., Gonzalo, O., Naval, J. & Marzo, I. (2013). Direct interaction of Bax and Bak proteins with Bcl-2 homology domain 3 (BH3)-only proteins in living cells revealed by fluorescence complementation. J Biol Chem 288, 4935–4946.
53. Walters, K. A., Syder, A. J., Lederer, S. L., Diamond, D. L., Paeper, B., Rice, C. M. & Katze, M. G. (2009). Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes. PLoS Pathog 5, e1000269.
54. Weber, A., Paschen, S. A., Heger, K., Wilfling, F., Frankenberg, T., Bauerschmitt, H., Seiffert, B. M., Kirschnek, S., Wagner, H. & Häcker, G. (2007). BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins. J Cell Biol 177, 625–636.
55. Woodhouse, S. D., Narayan, R., Latham, S., Lee, S., Antrobus, R., Gangadharan, B., Luo, S., Schroth, G. P., Klenerman, P. & Zitzmann, N. (2010). Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro. Hepatology 52, 443–453.
56. Yamane, D., McGivern, D. R., Wauthier, E., Yi, M., Madden, V. J., Welsch, C., Antes, I., Wen, Y., Chugh, P. E. & other authors (2014). Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation. Nat Med 20, 927–935.
57. Zhu, H., Dong, H., Eksioglu, E., Hemming, A., Cao, M., Crawford, J. M., Nelson, D. R. & Liu, C. (2007). Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Gastroenterology 133, 1649–1659.